Status:
COMPLETED
Evaluation of Carbohydrates Part 2
Lead Sponsor:
Abbott Nutrition
Conditions:
Gastro-Intestinal Tolerance
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The study is single-blind with a randomized, cross-over design to evaluate gastrointestinal tolerance of carbohydrate blends.
Eligibility Criteria
Inclusion
- Males or non-pregnant females in good health.
- Eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.
Exclusion
- Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes, cardio-vascular disease or GI disease.
- Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.
Key Trial Info
Start Date :
September 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2017
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03293706
Start Date
September 21 2017
End Date
November 15 2017
Last Update
December 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glycemic Index Laboratories, Inc.
Toronto, Ontario, Canada, M5C 2N8